However, it should be underlined that the therapeutic roles of VIP in experimentally induced colitis in rodents are controversial, because other studies (contrary to the above-mentioned) strongly suggest proinflammatory and pathogenic roles of VIP and suggest the use of VIP antagonists and VIP receptor blockades in the treatment of intestinal inflammatory processes [55]. The gene discussed is VIP; the disease is colitis.